Validation pour Ingenuity256

vers la météo de la validation par utilisateur

Ingenuity256

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 1 - PMID ?

In liver from male SP missing a adrenal gland , intravenous administration of NODE ( with a dosage of 50 mg/kg ) decreases expression of SP NODE mRNA(s) 72 hours after initial treatment .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 1

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 2

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 3

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 4

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 5

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 6

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 7

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 8

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 9

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 10

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 11

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 12

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 13

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 14

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 15

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 16

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 17

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 18

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 19

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 20

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 21

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 22

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 23

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 24

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 25

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 26

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 27

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 28

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 29

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 30

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 31

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 32

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 33

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 34

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 35

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 36

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 37

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 38

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 39

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 40

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 41

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 42

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 43

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 44

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 45

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 46

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 47

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 48

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 49

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 50

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 51

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 52

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 53

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 54

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 55

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 56

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 57

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 58

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 59

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 60

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 61

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 62

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 63

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 64

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 65

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 66

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 67

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 68

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 69

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 70

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 71

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 72

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 73

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 74

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 75

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 76

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 77

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 78

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 79

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 80

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 81

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 82

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 83

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 84

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 85

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 86

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 87

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 88

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 89

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 90

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 91

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 92

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 93

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 94

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 95

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 96

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 97

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 98

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 99

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 100

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 101

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 102

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 103

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 104

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 105

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 106

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 107

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 108

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 109

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 110

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 111

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 112

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 113

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 114

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 115

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 116

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 117

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 118

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 119

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 120

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 121

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 122

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 123

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 124

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 125

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 126

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 127

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 128

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 129

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 130

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 131

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 132

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 133

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 134

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 135

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 136

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 137

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 138

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 139

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 140

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 141

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 142

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 143

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 144

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 145

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 146

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 147

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 148

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 149

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 150

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 151

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 152

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 153

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 154

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 155

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 156

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 157

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 158

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 159

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 160

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 161

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 162

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 163

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 164

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 165

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 166

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 167

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 168

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 169

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 170

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 171

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 172

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 173

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 174

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 175

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 176

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 177

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 178

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 179

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 180

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 181

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 182

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 183

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 184

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 185

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 186

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 187

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 188

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 189

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 190

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 191

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 192

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 193

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 194

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 195

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 196

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 197

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 198

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 199

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 200

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 201

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 202

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 203

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 204

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 205

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 206

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 207

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 208

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 209

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 210

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 211

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 212

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 213

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 214

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 215

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 216

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 217

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 218

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 219

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 220

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 221

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 222

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 223

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                             
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                                      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 224

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 225

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 226

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 227

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 228

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 229

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 230

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 231

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 232

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 233

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 234

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 235

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 236

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 237

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 238

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 239

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +--------COMP:N-N(of)-------+                               |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 240

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 241

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 242

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 243

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 244

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 245

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 246

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 247

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 248

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 249

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 250

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 251

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 252

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 253

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 254

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                             
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 255

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                             
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 256

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 257

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 258

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                             
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 259

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                             
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 260

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 261

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 262

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 263

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 264

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 265

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 266

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 267

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 268

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 269

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 270

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 271

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+----------------------------COMP:V-N(after)---------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 272

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 273

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 274

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 275

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 276

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 277

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 278

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                             
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 279

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                             
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 280

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 281

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 282

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                             
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 283

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                             
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                                      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+--------COMP:N-N(after)--------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
COMP:N-N(after) (mRNA(s),treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 284

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 285

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 286

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 287

      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                             
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +----------------------COMP:N-N(after)----------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +--------COMP:N-N(of)-------+                               |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ-+                               |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_ATT+     +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |       |     |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA(s) 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA(s))
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA(s),__SP__)
MOD_ATT:N-ADJ (mRNA(s),__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)